As of March 2025 BridgeBio Pharma has a market cap of HK$50.44 Billion. This makes BridgeBio Pharma the world's 2285th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Mar 2nd, 2025 the market cap of BridgeBio Pharma was reported to be: